Furthermore, CHiP seq experiments in MCF-7 human breast cancer cells treated with the exogenous AHR agonist TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) identified AHR interactions with DNA from genes in the triglyceride pathway (Lo and Matthews, 2012). This evidence concerns the gene AHR and breast carcinoma.